Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre-exposure prophylaxis of COVID-19: A case series.

Kleiboeker, Hanna L; Jorgenson, Margaret R; Smith, Jeannina A

Kleiboeker, Hanna L; Jorgenson, Margaret R; Smith, Jeannina A.

Kleiboeker HL; Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA.
Jorgenson MR; Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA.
Smith JA; Department of Medicine, Division of Infectious Diseases, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Transpl Infect Dis ; : e13932, 2022 Aug 18.

Article in English | MEDLINE | ID: covidwho-1992907

Keywords

COVID-19; liver transplant; myalgia; tixagevimab/cilgavimab

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Tid.13932

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google